Therapeutic Asset Ratings

9,928 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
ide892 Peritoneal Mesothelioma	IDEAYA Biosciences	P1	CC (43)
ide892 Malignant Pleural Mesothelioma	IDEAYA Biosciences	P1	CC (43)
ide892 Esophageal Squamous Cell Carcinoma	IDEAYA Biosciences	P1	CC (43)
Idov-Immune Adrenal Gland Neoplasm	ViroMissile, Inc.	P1	CC (43)
Idov-Immune Cervical Cancer	ViroMissile, Inc.	P1	CC (43)
Idov-Immune Head And Neck Cancer	ViroMissile, Inc.	P1	CC (43)
Idp-023 CNS Demyelinating Autoimmune Disease	Indapta Therapeutics, INC.	P1	CC (43)
Idp-023 Immune System Disorder	Indapta Therapeutics, INC.	P1	CC (43)
Idp-023 Nervous System Disorder	Indapta Therapeutics, INC.	P1	CC (43)
Idp-023 Primary Progressive Multiple Sclerosis	Indapta Therapeutics, INC.	P1	CC (43)
Idp-023 Secondary Progressive Multiple Sclerosis	Indapta Therapeutics, INC.	P1	CC (43)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Gaucher Disease Type II	University of California, San Francisco	P1	CC (43)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Gaucher Disease Type III	University of California, San Francisco	P1	CC (43)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Mucopolysaccharidosis Type 2	University of California, San Francisco	P1	CC (43)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Mucopolysaccharidosis Type 4A	University of California, San Francisco	P1	CC (43)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Mucopolysaccharidosis Type 6	University of California, San Francisco	P1	CC (43)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Mucopolysaccharidosis Type 7	University of California, San Francisco	P1	CC (43)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Glycogen Storage Disease Due To Acid Maltase Deficiency, Infantile Onset	University of California, San Francisco	P1	CC (43)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Wolman Disease	University of California, San Francisco	P1	CC (43)
Ifa Plasma Cell Myeloma	Roswell Park Cancer Institute	P1	CC (43)
ik-595 Malignant Glioma	Ikena Oncology	P1	CC (43)
ik-595 Non-Small Cell Lung Carcinoma	Ikena Oncology	P1	CC (43)
ik-595 Thyroid Gland Carcinoma	Ikena Oncology	P1	CC (43)
iks014 Gastroesophageal Junction Adenocarcinoma	Iksuda Therapeutics Ltd.	P1	CC (43)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells Adrenal Cortex Carcinoma	Anusha Kalbasi	P1	CC (43)

Showing 2401 to 2425 of 9,928 assets

PreviousPage 97 of 398Next